10-year long-term survival (LTS) of induction chemotherapy with three cycles cisplatin/paclitaxel followed by concurrent chemoradiation cisplatin/etoposide/45Gy (1.5Gy bid) plus surgery in locally advanced non-small-cell lung cancer (NSCLC)—A multicenter phase-II trial (CISTAXOL)

✍ Scribed by Eberhardt, Wilfried Ernst Erich; Gauler, Thomas Christoph; LePechoux, Cecile; Stamatis, Georgios; Bildat, Stephan; Krbek, Thomas; Welter, Stefan; Grunenwald, Dominique; Fischer, Berthold; Rodrigo, Hepp de los Rios; Theegarten, Dirk; Le Chevalier, Thierry; Seeber, Siegfried; Stuschke, Martin; Poettgen, Christoph

• Book ID: 121332941
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 824 KB
• Volume: 82
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/j.lungcan.2013.06.007